Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2025-03-20 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed by Cellumed. It details the issuance of new shares, the purpose of the capital raise (operating funds), the third-party allocation method, and the specific financial details of the transaction. This falls under the category of announcements regarding new share issues or capital changes.
2025-03-20 Korean
소액공모공시서류(지분증권)
Share Issue/Capital Change Classification · 1% confidence The document is a '소액공모공시서류' (Small-scale Public Offering Disclosure Document) filed by Cellumed. It details a third-party allocation capital increase (유상증자) of less than 1 billion KRW, which exempts the company from filing a full securities registration statement (증권신고서). The document contains specific offering details, risk factors, and company information. According to the provided filing definitions, this falls under 'Share Issue/Capital Change' (SHA) as it relates to the issuance of new shares and capital structure changes.
2025-03-20 Korean
주권매매거래정지 (관리종목지정우려)
Delisting Announcement Classification · 1% confidence The document is a formal notice from the KOSDAQ exchange regarding the suspension of trading for Cellumed due to concerns about being designated as an administrative issue (management stock). It cites specific exchange regulations and provides the reason for the suspension (financial losses and capital impairment). Since this is a regulatory announcement regarding trading status and does not fit into specific categories like M&A or earnings, it falls under the general regulatory filing category.
2025-03-14 Korean
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
Delisting Announcement Classification · 1% confidence The document is a regulatory filing from a Korean company (Cellumed) regarding 'Internal Closing Financial Results' and the resulting 'Management Stock Designation' and 'Delisting/Listing Eligibility Review' triggers. It provides financial data (balance sheet, income statement) and explicitly states that these are internal, unaudited figures subject to change. In the context of Korean stock exchange filings (DART), this is a standard regulatory disclosure regarding financial distress and listing status, which falls under the 'Regulatory Filings' (RNS) category as it is a mandatory disclosure of material corporate events.
2025-03-14 Korean
기타시장안내(관리종목지정우려종목)
Regulatory Filings Classification · 1% confidence The document is a short regulatory notice from the Korea Exchange regarding Cellumed, warning about the potential designation as an administrative issue (management stock) due to capital impairment and operating losses. It is a regulatory announcement regarding market status and compliance, fitting the RNS category as it is a general regulatory filing that does not fall into specific financial reporting or corporate action categories.
2025-03-14 Korean
투자판단관련주요경영사항 (집행청구소송의 판결에 대한 항소의 건)
Legal Proceedings Report Classification · 1% confidence The document is a formal disclosure from Cellumed regarding an appeal filed in response to a court judgment in a litigation case. It details the parties involved, the grounds for the appeal, and the court of jurisdiction. This falls under the category of legal proceedings and litigation updates, which is classified as LTR (Legal Proceedings Report).
2025-03-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.